Financial reports
10-K
2023 FY
Annual report
21 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
3 May 23
ARS
2022 FY
Annual report to shareholders
28 Apr 23
10-K
2022 FY
Annual report
22 Feb 23
10-Q
2022 Q3
Quarterly report
2 Nov 22
10-Q
2022 Q2
Quarterly report
3 Aug 22
10-Q
2022 Q1
Quarterly report
4 May 22
10-K
2021 FY
Annual report
24 Feb 22
Current reports
8-K
Entry into a Material Definitive Agreement
29 Mar 24
8-K
United Therapeutics Corporation Announces $1 Billion Accelerated Share Repurchase Program
25 Mar 24
8-K
Other Events
27 Feb 24
8-K
United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
21 Feb 24
8-K
Other Events
20 Dec 23
8-K
Other Events
29 Nov 23
8-K
United Therapeutics Corporation Reports Third Quarter 2023 Financial Results
1 Nov 23
8-K
United Therapeutics Corporation Reports Second Quarter 2023 Financial Results
2 Aug 23
8-K
United Therapeutics Wins Appeal in Dry Powder Inhaler Patent Litigation
24 Jul 23
8-K/A
Submission of Matters to a Vote of Security Holders
14 Jul 23
Registration and prospectus
SC TO-T/A
Third party tender offer statement (amended)
13 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
12 Dec 23
SC TO-T/A
Third party tender offer statement (amended)
4 Dec 23
SC TO-T
Third party tender offer statement
13 Nov 23
SC TO-C
Information about tender offer
1 Nov 23
SC TO-C
Information about tender offer
30 Oct 23
SC TO-C
Information about tender offer
30 Oct 23
S-8
Registration of securities for employees
2 Aug 23
S-8
Registration of securities for employees
3 Aug 22
S-8
Registration of securities for employees
4 Aug 21
Proxies
DEFA14A
Additional proxy soliciting materials
28 Apr 23
DEF 14A
Definitive proxy
28 Apr 23
DEFA14A
Additional proxy soliciting materials
29 Apr 22
DEF 14A
Definitive proxy
29 Apr 22
DEFA14A
Additional proxy soliciting materials
10 Sep 21
DEFA14A
Additional proxy soliciting materials
19 Aug 21
DEF 14A
Definitive proxy
19 Aug 21
DEFA14A
Additional proxy soliciting materials
4 Aug 21
PRE 14A
Preliminary proxy
14 Jul 21
DEFA14A
Additional proxy soliciting materials
17 Jun 21
Other
CORRESP
Correspondence with SEC
13 Dec 23
SD
Conflict minerals disclosure
31 May 23
CT ORDER
Confidential treatment order
22 Feb 23
CT ORDER
Confidential treatment order
22 Feb 23
UPLOAD
Letter from SEC
10 Aug 22
CORRESP
Correspondence with SEC
9 Aug 22
UPLOAD
Letter from SEC
19 Jul 22
UPLOAD
Letter from SEC
14 Jul 22
SD
Conflict minerals disclosure
31 May 22
SD
Conflict minerals disclosure
1 Jun 21
Ownership